COPS7A

Mutation & survival
SurvivalMutationKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, COPS7A Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated COPS7A data layer compared with 20 for mass-spec protein and 7 for mass-spec protein.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher COPS7A Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated COPS7A expression acts as an unfavorable survival marker.

CESC and UCEC are the cancer types where COPS7A Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
CESCOSMedianII,III,IV0.1320.829<.00118view →
UCECOSMedianIV0.2310.592.0366view →
Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

COPS7A–CESC (OS)

Kaplan–Meier survival curve for COPS7A mutant vs wild-type samples in CESC.

Open the CESC breakdown →

Exploration